NCT02544789 Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT02544438 Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02535806 Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Status TERMINATED Phase PHASE2
NCT02535364 Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) Status TERMINATED Phase PHASE2
NCT02529813 CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies Status COMPLETED Phase PHASE1
NCT02518750 Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma Status TERMINATED Phase PHASE2
NCT02508038 Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors Status RECRUITING Phase PHASE1
NCT02500550 Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor Status COMPLETED Phase PHASE2
NCT02494882 Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02451774 Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction Status UNKNOWN Phase PHASE2/PHASE3
NCT02443831 CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia Status RECRUITING Phase PHASE1
NCT02404220 Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE1/PHASE2
NCT02373579 Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT02369653 A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase Status COMPLETED Phase PHASE3
NCT02339350 Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children Status UNKNOWN Phase PHASE2
NCT02336282 Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT02315612 Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies Status COMPLETED Phase PHASE1
NCT02310243 Study of Palbociclib in MLL-rearranged Acute Leukemias Status UNKNOWN Phase PHASE1/PHASE2